Recent Quotes (30 days)

You have no recent quotes
chg | %

Luminor Medical Technologies Inc  

(Public, CVE:LMT)   Watch this stock  
Find more results for CVE:MOM
-0.020 (-3.70%)
Mar 24 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.52 - 0.52
52 week 0.14 - 0.75
Open 0.52
Vol / Avg. 1,740.00/16,481.00
Mkt cap 4.87M
P/E     -
Div/yield     -
EPS -1.03
Shares 9.37M
Beta 0.32
Inst. own     -

Key stats and ratios

Q3 (Aug '16) 2015
Net profit margin - -35914.64%
Operating margin - -30978.80%
EBITD margin - -19607.43%
Return on average assets -261.25% -220.52%
Return on average equity - -
CDP Score - -


6-1250 Waverley St
+1-204-4531408 (Phone)
+1-204-4531546 (Fax)

Website links


Luminor Medical Technologies Inc., formerly Miraculins Inc., is a Canada-based medical diagnostic company. The Company is focused on acquiring, developing and commercializing non-invasive technologies for various clinical needs. It offers Scout DS device, which is a clinical tool to assist in the identification of both pre-diabetes and type 2 diabetes, and is a non-invasive testing system that provides a method for measuring pre-diabetes/type 2 diabetes related biomarkers in the skin. The Company is in various stages of development of diagnostic and risk assessment products.

Officers and directors

Harry J F Bloomfield Independent Chairman of the Board
Age: 70
Christian Sauvageau President, Chief Executive Officer, Director
Christopher A. Carmichael CPA Chief Financial Officer
Daniel Cloutier Director
Ashwath Mehra Director